At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 54 enrolled
Drug / intervention
10 g ethanol +4 moredietary
Likely dose
10 g ethanolfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Identifying the Profile of the Main Non-oxidative Biomarkers of Alcohol (Ethyl Glucuronide, Ethyl Sulphate, Fatty Acid Ethyl Esters) After the Experimental Exposure to Increasing Doses of Alcohol in Adults.
In Brief
A Phase 1 clinical trial evaluating 10 g ethanol, 20 g ethanol, and 3 other interventions for Alcohol Consumption and Healthy. Completed, enrolled 54 participants across 1 site.
Detailed Summary
The aim of the study is to study the profile of ethanol and non-oxidative biomarkers (ethyl glucuronide, ethyl sulphate and fatty acid ethyl esters) after experimental administration of increasing doses of alcohol in adult subjects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcohol Consumption, Healthy
CountriesSpain
Collaborators--
Timeline
Phase 1CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartDec 2014
First PostedDec 2014
Primary CompletionMay 2016
TodayJul 2026
First PostedDec 8, 2014
Enrollment StartDec 1, 2014
Primary CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 11.6 years ago
Interventions
10 g ethanoldietary
Alcohol single oral dose
20 g ethanoldietary
Alcohol single oral dose
40 g ethanoldietary
Alcohol single oral dose
60 g ethanoldietary
Alcohol single oral dose
80 g ethanoldietary
Alcohol single oral dose